https://orcid.org/0000-0003-2387-415X
References
- Drug Overdose Deaths in the U.S. Top 100,000 annually [Internet]; 2021 [accessed 2022 Jan 25]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm.
- Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(50-51):1445–52. doi:10.15585/mmwr.mm655051e1.
- Pergolizzi JV, Gharibo CG, Gudin JA, Nalamachu SR. Development of federally mandated risk evaluation and mitigation strategies (REMS) for transmucosal immediate-release fentanyl products. Pain Pract. 2013;13(4):259–63. doi:10.1111/papr.12040.
- Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Med. 2015;16(suppl 1):S3–S8. doi:10.1111/pme.12904.
- Brown JH, Torres HP, Maddi RD, Williams JL, Dibaj SS, Liu D, Bruera E. Cancer patients’ perceived difficulties filling opioid prescriptions after receiving outpatient supportive care. J Pain Symptom Manage. 2020;60(5):915–22. doi:10.1016/j.jpainsymman.2020.06.015.
- D-35.981 AMA response to pharmacy intrusion into medical practice | AMA [Internet]; 2013 [accessed 2022 Jan 25]. https://policysearch.ama-assn.org/policyfinder/detail/AMA.ResponsetoPharmacyIntrusionIntoMedicalPracticeD-35.981?uri=%2FAMADoc%2Fdirectives.xml-0-1172.xml.
- Guillou Landreat M, Dany A, Challet Bouju G, Laforgue E-J, Cholet J, Leboucher J, Hardouin JB, Victorri Vigneau C, Grall Bronnec M, OPAL Group. How do people who use drugs receiving opioid medication therapy perceive their treatment ? A multicentre study. Harm Reduct J. 2022;19(1):31. doi:10.1186/s12954-022-00608-6.
- Arnold A, Bentley JP, Patel A, Holmes E. Predictors of pharmacists’ likelihood to query prescription drug monitoring program databases. J Am Pharm Assoc. 2021;61(5):614–22.e3. doi:10.1016/j.japh.2021.04.019.
- Joranson DE, Gilson AM. Pharmacists’ knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J Am Pharm Assoc. 2001;41(2):213–20.
- Balough M, Nwankpa S, Unni E. Readiness of pharmacists based in Utah about pain management and opioid dispensing. Pharmacy. 2019;7(1):11. doi:10.3390/pharmacy7010011.
- Strand MA, Eukel H, Burck S. Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk. Res Social Adm Pharm. 2019;15(8):1032–6. doi:10.1016/j.sapharm.2018.07.011.
- Nielsen S, Sanfilippo P, Picco L, Bruno R, Kowalski M, Wood P, Larney S. What predicts pharmacists’ engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy. Int J Clin Pharm. 2021;43(2):420–9. 10.1007/s11096-020-01074-5.